Melanoma inhibitory activity (MIA). Evaluation of a novel tumorassociated antigen as a serum marker for uveal melanoma;Melanoma inhibitory activity (MIA). Evaluierung eines neuen tumorassoziierteten antigens als serummarker fur uveale melanome

Ophthalmologe

Volumn 97, Issue 6, 2000, Pages 429-432

  Schaller, U C ^a   Mueller, A J ^a   Bosserhoff, A K ^c   Haraida, S ^b   Lohrs U ^b   Buettner, R ^c   Kampik, A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c NONE

Author keywords

Metastasis; Serum marker MIA; Uveal melanoma

Indexed keywords

TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MALE; MELANOMA; UVEA TUMOR;

AGED; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 0033919331     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470070093     Document Type: Article

References (23)

1. Albert DM, Niffenegger AS, Willson JKV (1992) Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 36:429-438
2. Augsburger JJ, Gamel JW, Lauritzen K, Brady LW (1990) Cobald-60 plaque radiotherapy vs enucleation for posterior uveal melanoma. Am J Ophthalmol 109:585-592
3. Blesch A, Bosserhoff AK, Apfel R et al. (1994) Cloning of a malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 54:5695-5701
4. Bornfeld N. (1992) Diagnose und Therapie maligner Melanome der Uvea (Aderhaut und Ziliarkörper). Ophthalmologe 89:W61-W78
5. Bosserhoff AK, Kaufmann M, Kaluza B et al. (1997) Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 57:3149-3153
6. Bosserhoff AK, Golob M, Buettner R, Landthaler M, Hein R (1998) MIA (melanoma inhibitory activity) Biologische Funktion und klinische Relevanz beim malignen Melanom. Hautarzt 49:762-769
7. Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R (1999) In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancer. J Pathol 187:446-454
8. Collaborative Ocular Melanoma Study Group (1990) Accuracy of diagnosis of posterior uveal melanomas. Arch Ophthalmol z:1268-1273
9. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP (1992) A review of mortality from choroidal melanoma. Arch Ophthalmol 110:245-250
10. Eskelin S, Pyrhonen S, Summanen P, Prause JU, Kivela T (1999) Screening for metastatic malignan melanoma of the uvea revisited. Cancer 85:1151-1159
11. Folberg R, Rummelt V, Ginderdeuren van RP, Hwang T, Woolson RF, Peer J, Gruman LM (1993) The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100:1389-1398
12. Goto H, Tenou T, Kudo H, Iwasaki T, Usui M, Wakamatsu K, Ito S (1998) 5-S-Cysteinyldopa as a diagnostic tumor marker for uveal melanoma. Nippon Ganka Gakkai Zasshi 102:319-326.
13. Gragoudas ES, Egan KM, Seddon JM et al. (1990) Survival of patients with metastases from uveal melanoma. Ophthalmology 98:383-390
14. Kuan AK, Jackson FI, Hanson J (1988) Multimodality detection of metastatic melanoma. J R Soc Med 81:579-582
15. Mooy CM, DeJong PTVM (1996) Prognostic parameter in uveal melanoma: a review. Surv Ophthalmol 41:215-228
16. Mueller AJ, Bartsch DU, Folberg R et al. (1998) Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 116:31-39
17. Mueller AJ, Freeman WR, Folberg R, Bartsch DU, Scheider A, Schaller U, Kampik A (1999) Evaluation of microcirculation pattern visibility in human choroidal melanomas: comparison of confocal fluorescein with indocyanine green angiography.Graefe's Arch Clin Exp Ophthalmol 237:448-456
18. Mueller AJ, Wowra B, Talies S et al. (im Druck) Die stereotaktische Präzisionsbestrahlung großer uvealer Melanome mit dem Gammaknife. Ophthalmologe
19. Pach JM, Robertson DM (1986) Metastasis from untreated uveal melanoma. Arch Ophthalmol 104:1624-1625
20. Renie I, Forster D, Kemeny A, Walton L Kunkler I (1996) The use of single fraction leksell stereotactic radiosurgery in the treatment of uveal melanoma. Acta Ophthalmol Scand 74:558-562
21. Schaller UC, Mueller AJ, Bosserhoff AK, Buettner R, Stefani F, Kampik A (1999) Evaluation of the novel tumorassociated antigen melanoma inhibitory activity (MIA) as a serum marker for uveal melanoma. IOVS 40:184
22. Tang NEML, Bonfrer JMG, de Wolff-Rouendaal D, Keunen JEE, Jager MJ (1998) Prognostic value of S-100 serum concentration in patients with uveal melanoma. IOVS 39:289
23. Terheyden P, Kämpgen E, Rünger TM, Bröcker EB, Becker JC (1998) Immunochemotherapie des metastasierenden Uveamelanoms mit Interferon-2b, Interleukin-2 und Fotemustin. Hautarzt 49:770-773